Laboratory Corporation of America Holdings

143.01+1.85+1.31%Vol 26.26K1Y Perf -11.09%
Apr 9th, 2020 09:33
BID142.07 ASK143.55
Open144.67 Previous Close133.45
Pre-Market144.00 After-Market142.00
 2.84 2.01%  0.84 0.60%
Target Price
185.54 
Analyst Rating
Strong Buy 1.54
Potential %
31.44 
Finscreener Ranking
★+     43.89
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     46.75
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★+     48.45
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap13.89B 
Earnings Rating
Sell
Price Range Ratio 52W %
45.75 
Earnings Date
29th Apr 2020

Today's Price Range

142.00144.78

52W Range

98.02196.36

5 Year PE Ratio Range

10.1033.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
21.68%
1 Month
-19.84%
3 Months
-19.30%
6 Months
-14.63%
1 Year
-11.09%
3 Years
-1.56%
5 Years
11.97%
10 Years
85.35%

TickerPriceChg.Chg.%
LH143.011.85001.31
AAPL267.771.70000.64
GOOG1 216.656.37000.53
MSFT165.12-0.0100-0.01
XOM45.011.16002.65
WFC31.150.87002.87
JNJ144.681.42000.99
FB174.900.62000.36
GE7.420.12001.64
JPM97.373.07003.26
Earnings HistoryEstimateReportedSurprise %
Q04 20192.802.862.14
Q03 20192.842.902.11
Q02 20192.902.931.03
Q01 20192.532.623.56
Q04 20182.482.521.61
Q03 20182.872.74-4.53
Q02 20182.922.982.05
Q01 20182.642.785.30
Earnings Per EndEstimateRevision %Trend
3/2020 QR2.54-6.62Negative
6/2020 QR1.90-39.30Negative
12/2020 FY10.31-13.72Negative
12/2021 FY12.60-1.10Negative
Next Report Date29th Apr 2020
Estimated EPS Next Report2.35
Estimates Count7
EPS Growth Next 5 Years %5.30
Volume Overview
Volume26.26K
Shares Outstanding97.10M
Trades Count562
Dollar Volume8.88M
Avg. Volume1.02M
Avg. Weekly Volume1.12M
Avg. Monthly Volume1.37M
Avg. Quarterly Volume1.05M

Laboratory Corporation of America Holdings (NYSE: LH) closed at 141.16 per share at the end of the most recent trading day (a 5.78% change compared to the prior day closing price) with a volume of 1.13M shares and market capitalization of 13.89B. Is a component of S&P 500, Russell 1000 indexes and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61000 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is -11.09%, while year-to-date (YTD) performance is -16.56%. LH stock has a five-year performance of 11.97%. Its 52-week range is between 98.02 and 196.36, which gives LH stock a 52-week price range ratio of 45.75%

Laboratory Corporation of America Holdings currently has a PE ratio of 13.60, a price-to-book (PB) ratio of 1.45, a price-to-sale (PS) ratio of 1.40, a price to cashflow ratio of 7.70, a PEG ratio of 2.32, a ROA of 4.87%, a ROC of 7.24% and a ROE of 11.46%. The company’s profit margin is 7.29%, its EBITDA margin is 16.60%, and its revenue ttm is $8.76 Billion , which makes it $90.25 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.35 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 29th Apr 2020.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.54), with a target price of $185.54, which is +31.44% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 30.92, ATR14 : 11.80, CCI20 : 114.41, Chaikin Money Flow : 0.04, MACD : -8.48, Money Flow Index : 52.42, ROC : 19.86, RSI : 51.74, STOCH (14,3) : 91.00, STOCH RSI : 1.00, UO : 53.81, Williams %R : -9.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), David P. King (Option Excercise at a value of $0), David P. King (Sold 60 354 shares of value $9 982 432 ), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Glenn A. Eisenberg (Sold 15 563 shares of value $2 657 230 ), Jean-Luc Belingard (Option Excercise at a value of $239 289), Jean-Luc Belingard (Sold 26 479 shares of value $5 024 750 ), Kerrii B. Anderson (Option Excercise at a value of $495 363), Kerrii B. Anderson (Sold 5 700 shares of value $973 810 ), Lance V. Berberian (Option Excercise at a value of $0), Lance V. Berberian (Sold 11 804 shares of value $2 004 344 ), Lisa J. Uthgenannt (Option Excercise at a value of $322 060), Lisa J. Uthgenannt (Sold 6 466 shares of value $1 071 743 ), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 296 shares of value $55 091 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $0), Peter J. Wilkinson (Sold 297 shares of value $56 326 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert E. Mittelstaedt (Option Excercise at a value of $238 354), Robert E. Mittelstaedt (Sold 3 700 shares of value $615 310 ), Robert Sanders Williams (Option Excercise at a value of $0), Robert Sanders Williams (Sold 2 227 shares of value $393 832 ), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 5 338 shares of value $949 769 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (66.67 %)
9 (69.23 %)
9 (75.00 %)
Moderate Buy
1 (8.33 %)
1 (7.69 %)
1 (8.33 %)
Hold
3 (25.00 %)
3 (23.08 %)
2 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.54
Strong Buy
1.50
Strong Buy
1.38

Laboratory Corporation of America Holdings

Laboratory Corporation of America is the nation's second- largest independent clinical laboratory, with roughly 20% of the independent lab market. The company operates more than 1,800 patient-service centers, offering a broad range of clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

CEO: Adam H. Schechter

Teplephone: +1 336 229-1127

Address: 358 South Main Street, Burlington 27215, NC, USA

Number of employees: 61 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

43%57%

Bearish Bullish

52%48%

News

Stocktwits